Paracetamol inhibits copper ion-induced, azo compound-initiated, and mononuclear cell-mediated oxidative modification of LDL

Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1338-44. doi: 10.1161/01.atv.15.9.1338.

Abstract

The effects of paracetamol and sodium salicylate on the susceptibility of LDL to oxidative modification were studied. LDL was subjected to Cu(2+)-, azo compound-, or peripheral blood mononuclear cell-initiated oxidation in the absence and presence of paracetamol and salicylate. Paracetamol (100 mumol/L; 25 micrograms LDL/mL) reduced the rate of formation of conjugated dienes and the amount of conjugated dienes formed during Cu(2+)-induced oxidation by 67% and 58%, respectively. Paracetamol (400 mumol/L; 100 micrograms LDL/mL) reduced the generation of lipid peroxides during Cu(2+)-induced oxidation by 43% (P < .05), the relative electrophoretic mobility in agarose gels by 16% (P < .05), and the amount of oxidized LDL taken up by J774 macrophages by 22% (P < .05). Paracetamol (100 mumol/L; 100 micrograms LDL/mL) reduced the 2,2'-azobis-(2-amidinopropane hydrochloride)-initiated lipid peroxidation by 70% (P < .05) and the relative electrophoretic mobility by 34% (P < .05). Paracetamol (100 mumol/L; 100 micrograms LDL/mL) reduced the amount of lipid peroxides generated in LDL during mononuclear cell-mediated oxidation by 69% (P < .01) and the relative electrophoretic mobility by 38% (P < .01). In comparison, 10 mumol/L alpha-tocopherol reduced the amount of lipid peroxides formed during cellular LDL oxidation and the relative electrophoretic mobility by 52% and 65%, respectively (P < .05). In the absence of paracetamol, SOD and catalase inhibited the modification of LDL (P < .05), suggesting that superoxide anions and hydrogen peroxide might be involved in the cell-mediated modification pathway. In the presence of paracetamol, SOD showed no additional inhibitory effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / pharmacology*
  • Amidines / pharmacology*
  • Bepridil / analogs & derivatives
  • Biphenyl Compounds
  • Catalase / pharmacology
  • Copper / pharmacology*
  • Free Radical Scavengers
  • Humans
  • Kinetics
  • Leukocytes, Mononuclear / metabolism*
  • Lipid Peroxidation / drug effects*
  • Lipoproteins, LDL / metabolism*
  • Picrates*
  • Salicylates / pharmacology
  • Salicylic Acid
  • Superoxide Dismutase / pharmacology

Substances

  • Amidines
  • Biphenyl Compounds
  • Free Radical Scavengers
  • Lipoproteins, LDL
  • Picrates
  • Salicylates
  • Acetaminophen
  • 2,2'-azobis(2-amidinopropane)
  • Bepridil
  • Copper
  • 1,1-diphenyl-2-picrylhydrazyl
  • Catalase
  • Superoxide Dismutase
  • Salicylic Acid